President, Asia PacificDanaher, Videojet Technologies, Inc. ShanghaiMember of the Danaher China BoardResponsible for the Asia Pacific region delivering Sales, OP and Working capital. 07 sales of US$ 107.5M and operating profit at 21% of sales. 07 headcount is 548 persons. I led a localization initiative through the establishment of a local R&D center in Shanghai. General Manager, Vice President-Asia Pacific(January 1998 - December 2003) Danaher, Videojet-Willett Technologies, Inc. ShanghaiAt Videojet, lead and managed the team to grow the business in APAC from US$ 54.1M` to US$ 89.7M from 2003 to 2006 through M&A and organic growth: more than 26% in China, over 40% in India, 22% in Korea. In China, took the Videojet brand from number 5 in awareness to number 2; launched a range of products for the local market and indigenous customer base in China and India; in 2004 relocated the regional head quarters from Singapore to Shanghai leading the region through a regional team.

General Manager (January 1997 to December 1997) Kaneka Pharmaceutical, SingaporeResponsible for building the bulk active pharmaceutical and dosage operations for Sinova, a subsidiary of Kaneka, headquarters in Osaka, Japan. Functional reporting included Sales & Marketing, Logistics, Finance, Human Resources and Production.

Director of Sales and Marketing – Asia Pacific(Mar 1994 to Dec 1996) Pfizer Inc, SingaporeConceived and implemented the entry strategy in China.Built a high performance Sales & Marketing team in China, S East Asia and India. Led the organization to focus on therapeutic specialty productsMarketing Manager – World wide(Mar 1989 to Feb 1994) Pfizer Inc, New York Responsible for establishing Global Business plans for two therapeutic products targeted primarily in the US, Europe and South East Asia. Led the Go to Market strategy and launch of these products.I grew the product franchise from US$45 million to US$268 million in 3.5 years. I created a vision for the product group that was articulated into a mission statement. This led to strategies achieving dramatic cost reductions at the plant, Sales growth via target channel initiatives and R&D programs linked to market unmet needsNegotiated two license agreements while successfully implemented two worldwide price increase